FDA Commissioner Marty Makary (Jose Luis Magana/AP Images)
FDA head Makary’s short-lived CRL ask on KalVista’s drug raises more concerns of political intervention
FDA Commissioner Marty Makary’s unsuccessful attempt to intervene in an ongoing drug review, as described by multiple agency sources, raises further concerns …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
